157733-72-7

Upstream product

• 139627-94-4 (2S,4R)-5-Hydroxy-2,4-dimethyl-pentanoic acid methyl ester 
• 82917-26-8 [2R,4S]-5-hydroxy-2,4-dimethyl-pentanoic acid methyl ester 
• 139571-18-9 {(2S,4S)-8-[2-((R)-4-Benzyloxymethyl-hexyl)-[1,3]dioxolan-2-yl]-2,4-dimethyl-octyloxy}-tert-butyl-dimethyl-silane 
• 157733-70-5 (R)-5-{2-[(5S,7S)-8-(tert-Butyl-dimethyl-silanyloxy)-5,7-dimethyl-octyl]-[1,3]dioxolan-2-yl}-2-ethyl-pentan-1-ol 
• 157733-60-3 (2S,4R)-methyl 5-benzyloxy-2,4-dimethyl-pentanoate 
• 157733-61-4 (2'R,4'S)-<5'-<(tert-butyldimethylsilyl)oxy>-2',4'-dimethyl-pentyloxymethyl>benzene 
• 157810-31-6 (2S,4R)-5-(benzyloxy)-2,4-dimethylpentan-1-ol 
• 157733-59-0 [2R,4S]-5-(tert-butyl-dimethyl-silanyloxy)-2,4-dimethyl-pentanoic acid methyl ester 
• 139627-93-3 (2R,4S)-5-<(tert-butyldimethylsilyl)oxy>-2,4-dimethyl-pentanal 
• 69739-34-0 t-butyldimethylsiyl triflate 
• 16844-27-2 p-toluenesulfinic acid lithium salt 
• 157733-71-6 tert-Butyl-{(2S,4S)-8-[2-((R)-4-iodomethyl-hexyl)-[1,3]dioxolan-2-yl]-2,4-dimethyl-octyloxy}-dimethyl-silane 

Downstream Products

• 139571-19-0 (2S,4S)-2,4-Dimethyl-8-{2-[(R)-4-(toluene-4-sulfonylmethyl)-hexyl]-[1,3]dioxolan-2-yl}-octan-1-ol 

Relevant academic research and scientific papers

A Highly Convergent Total Synthesis of (+)-Myxovirescine M2

The antibiotic myxovirescine M2 was synthesized from seven building blocks (1-7, Scheme 1), with the following chiral starting materials being employed : (S)-malic acid, (+)-D-ribonolactone, (S)-2-(hydroxymethyl)butanoate, and (2R,4S)-5-hydroxy